Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan for Microvascular Function in Postpartum Preeclampsia
NCT04632589Phase 1Completed
- Start
- Nov 2020
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial in preeclampsia comparing Losartan with Placebo (2 arms). Primary endpoints: Cutaneous Conductance (%Maximum) Response to Acetylcholine at 6 weeks and Cutaneous Conductance (%Baseline) Response to Angiotensin II at 6 weeks. Started Nov 2020; status: completed.
02
Drugs
losartan
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT04632589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04632589.